A Simplified Low Iodine Diet in I-131 Scanning and Therapy of Thyroid Cancer
Published Dec 1, 1988 · M. Lakshmanan, A. Schaffer, Jacob Robbins
Clinical Nuclear Medicine
Q2 SJR score
87
Citations
0
Influential Citations
Abstract
A simplified, low iodine diet was developed for outpatient use prior to I-131 scanning and therapy in thyroid cancer. Iodine intake of five subjects on the diet was approximately 50 µg a day and this level was maintained for four weeks. The diet required only minimal instruction to be followed reliably. This level of iodine intake may increase radioiodine uptake in thyroid carcinomas.
Study Snapshot
Key takeawayA simplified low iodine diet can effectively increase radioiodine uptake in thyroid cancer patients, making it suitable for outpatient use prior to I-131 scanning and therapy.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Sign up or log in to use Study Snapshot and unlock more functionality.
Preparation for radioiodine therapy in patients with differentiated thyroid cancer, modern perspective. Review of the literature.
Preparation for radioiodine therapy in patients with differentiated thyroid cancer should be based on leading expert societies' recommendations and studies, with a focus on side effects and long-term treatment outcomes.
2023·0citations·Maria V. Ryzhenko et al.·Digital Diagnostics
Digital Diagnostics
Genome-Wide Pleiotropy Study Identifies Association of PDGFB with Age-Related Macular Degeneration and COVID-19 Infection Outcomes
PDGFB is associated with age-related macular degeneration and severe COVID-19 outcomes, suggesting that PDGFB may play a role in both diseases.
2022·3citations·Jaeyoon Chung et al.·Journal of Clinical Medicine
Journal of Clinical Medicine
The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
A low-iodine diet 200 g/day may worsen progression-free survival in radioactive iodine-treated differentiated thyroid cancer patients, but distant metastases are a strong independent predictor of progression.
2022·1citations·Hongxiu Luo et al.·Frontiers in Pharmacology
Frontiers in Pharmacology
Impact of low iodine diets on ablation success in differentiated thyroid cancer: A mixed‐methods systematic review and meta‐analysis
Low iodine diets before radioactive-iodine treatment for differentiated thyroid cancer may improve treatment success, but their duration and stringency need further research.
2022·2citations·G. Herbert et al.·Clinical Endocrinology
Clinical Endocrinology
Influence of Levothyroxine with Recombinant Human TSH on Urine Iodine Excretion Before Radioactive Iodine Administration.
Stimulation with recombinant human TSH before radioactive iodine administration slightly increases the body iodine pool in thyroid cancer patients.
2021·1citations·K. Fujimoto et al.·Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
SNMMI Procedure Standard for Scintigraphy for Differentiated Thyroid Cancer
Nuclear medicine and molecular imaging, with a focus on cancer diagnosis and treatment.
2020·7citations·Twyla B. Bartel (Chair) et al.·The Journal of Nuclear Medicine Technology
The Journal of Nuclear Medicine Technology
Low iodine diet in differentiated thyroid cancer: a review
A low iodine diet before radioactive iodine ablation may enhance the effectiveness of the treatment for differentiated thyroid cancer, but more large-scale randomized controlled trials are needed to confirm its crucial role.
2016·37citations·Josephine H. Li et al.·Clinical Endocrinology
Clinical Endocrinology
Low iodine diet does not improve the efficacy of radioiodine for the treatment of Graves' disease.
A low-iodine diet does not improve the efficacy of radioiodine for treating Graves' disease, even with sufficient or mild excess iodine intake.
2015·6citations·Vanessa A. Santarosa et al.·Archives of endocrinology and metabolism
Archives of endocrinology and metabolism